HIV-1 Subtype C-Infected Individuals Maintaining High Viral Load as Potential Targets for the “Test-and-Treat” Approach to Reduce HIV Transmission
暂无分享,去创建一个
Sikhulile Moyo | Victor DeGruttola | Shahin Lockman | C. William Wester | Vladimir Novitsky | P. Gilbert | S. Lockman | V. DeGruttola | I. Thior | G. Seage | M. Mine | Rui Wang | M. Essex | V. Novitsky | R. Marlink | S. Moyo | R. Musonda | Ibou Thior | Richard Marlink | A. Campa | R. Shapiro | Roger Shapiro | Peter Gilbert | Rui Wang | Rosemary Musonda | Erik van Widenfelt | Joseph Makhema | M. Baum | George R. Seage | Anthony Ogwu | M. Essex | Hermann Bussmann | Marianna Baum | Carolyn Wester | Aida Asmelash | Adriana Campa | Madisa Mine | Claire Moffat | Mompati Mmalane | J. Makhema | C. Wester | A. Ogwu | C. Wester | H. Bussmann | M. Mmalane | E. van Widenfelt | C. Moffat | A. Asmelash | Claire Moffat | Carolyn N Wester | Carolyn Wester | Landon Myer | William Wester | Iii | Citation Novitsky | Wang R Bussmann | Lockman S Baum | C. Wester
[1] Michael J Silverberg,et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. , 2009, The New England journal of medicine.
[2] Xiaohua Xia,et al. Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa. , 2005, AIDS research and human retroviruses.
[3] Lawrence Corey,et al. Biological and Virologic Characteristics of Primary HIV Infection , 1998, Annals of Internal Medicine.
[4] S. Lockman,et al. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. , 2005, The Journal of infectious diseases.
[5] J. Mellors,et al. Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion , 1995, Annals of Internal Medicine.
[6] P. Vernazza,et al. High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. , 1998, The Journal of infectious diseases.
[7] T. Quinn,et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. , 2000, The New England journal of medicine.
[8] Christophe Fraser,et al. HIV-1 transmission, by stage of infection. , 2008, The Journal of infectious diseases.
[9] O. Laeyendecker,et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. , 2005, The Journal of infectious diseases.
[10] Roger Detels,et al. Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.
[11] S. Lagakos,et al. Timing Constraints of In Vivo Gag Mutations during Primary HIV-1 Subtype C Infection , 2009, PloS one.
[12] D. Kuritzkes,et al. Higher-Than-Expected Rates of Lactic Acidosis Among Highly Active Antiretroviral Therapy-Treated Women in Botswana: Preliminary Results from a Large Randomized Clinical Trial , 2007, Journal of acquired immune deficiency syndromes.
[13] I Spijkerman,et al. AIDS prognosis based on HIV‐1 RNA, CD4+ T‐cell count and function: markers with reciprocal predictive value over time after seroconversion , 1997, AIDS.
[14] V. Robison,et al. Male Viral Load and Heterosexual Transmission of HIV‐1 Subtype E in Northern Thailand , 2002, Journal of acquired immune deficiency syndromes.
[15] S. Lagakos,et al. Viral Load and CD4+ T-Cell Dynamics in Primary HIV-1 Subtype C Infection , 2009, Journal of acquired immune deficiency syndromes.
[16] J. Overbaugh,et al. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. , 2001, The Journal of infectious diseases.
[17] James A McIntyre,et al. Early antiretroviral therapy and mortality among HIV-infected infants. , 2008, The New England journal of medicine.
[18] J. Goedert,et al. Virus load and risk of heterosexual transmission of human immunodeficiency virus and hepatitis C virus by men with hemophilia. The Multicenter Hemophilia Cohort Study. , 2000, The Journal of infectious diseases.
[19] V. DeGruttola,et al. The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa. , 2007, AIDS research and human retroviruses.
[20] M. Essex,et al. Identification of primary HIV-1C infection in Botswana , 2008, AIDS care.
[21] D R Hoover,et al. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. , 2001, The New England journal of medicine.
[22] Sikhulile Moyo,et al. Evolution of proviral gp120 over the first year of HIV-1 subtype C infection. , 2009, Virology.
[23] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[24] W. Tsai,et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. , 2008, The New England journal of medicine.
[25] David Hinkley,et al. Bootstrap Methods: Another Look at the Jackknife , 2008 .
[26] S. Lagakos,et al. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. , 2007, The New England journal of medicine.
[27] S. Lagakos,et al. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana , 2006, AIDS.
[28] Lynne Peeples,et al. Class-sparing regimens for initial treatment of HIV-1 infection. , 2008, The New England journal of medicine.
[29] W. Blattner,et al. Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS. , 2004, The Journal of infectious diseases.
[30] R. Walensky. Cost-effectiveness of HIV interventions: from cohort studies and clinical trials to policy. , 2009, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[31] V. DeGruttola,et al. Response to Zidovudine/Didanosine-Containing Combination Antiretroviral Therapy Among HIV-1 Subtype C-Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial , 2009, Journal of acquired immune deficiency syndromes.
[32] Douglas D. Richman,et al. Viral Dynamics of Acute HIV-1 Infection , 1999, The Journal of experimental medicine.
[33] S. Lockman,et al. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. , 2007, The Journal of infectious diseases.
[34] M. Essex,et al. A seronegative case of HIV-1 subtype C infection in Botswana. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] Christopher Dye,et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model , 2009, The Lancet.
[36] D. Ho,et al. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. , 1991, The New England journal of medicine.
[37] M. Moroni,et al. Plasma Viral Load Concentrations in Women and Men From Different Exposure Categories and With Known Duration of HIV Infection , 2000, Journal of acquired immune deficiency syndromes.
[38] D. Cooper,et al. Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group. , 1998, The Journal of infectious diseases.
[39] R H Lyles,et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. , 2000, The Journal of infectious diseases.
[40] T. Taha,et al. Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] J. Margolick,et al. Sex differences in HIV-1 viral load and progression to AIDS , 1998, The Lancet.
[42] S. Lagakos,et al. Better Control of Early Viral Replication Is Associated With Slower Rate of Elicited Antiviral Antibodies in the Detuned Enzyme Immunoassay During Primary HIV-1C Infection , 2009, Journal of acquired immune deficiency syndromes.
[43] F. Vannberg,et al. Human Immunodeficiency Virus Type 1 Subtype C Molecular Phylogeny: Consensus Sequence for an AIDS Vaccine Design? , 2002, Journal of Virology.
[44] S. Vermund,et al. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression , 2008, AIDS.
[45] S. Vermund,et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. , 2001, AIDS research and human retroviruses.
[46] M. Fowler,et al. Predictors of Early and Late Mother-to-Child Transmission of HIV in a Breastfeeding Population: HIV Network for Prevention Trials 012 Experience, Kampala, Uganda , 2009, Journal of acquired immune deficiency syndromes.
[47] Peter B Gilbert,et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. , 2006, JAMA.